New NICE criteria for drug access.
Janet
J
Fricker
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D004739:England; D033161:Government Regulation; D006291:Health Policy / Q000191:economics* / Q000331:legislation & jurisprudence; D006297:Health Services Accessibility / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D011050:Policy Making; D013222:State Medicine / Q000191:economics* / Q000331:legislation & jurisprudence
D000970:Antineoplastic Agents